PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic JournalOpen Access

Pain Management

1 Papers Indexed in Blossom

Data updated April 24, 2026

Research Footprint

Pain Management has 1 tracked paper indexed in Blossom (2026) from 5 authors, most often covering Ketamine, across Neuroimaging & Brain Measures, Depressive Disorders and Chronic Pain.

Published Papers

Paywallindividual

Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depression

This randomised, double-blind, placebo-controlled trial protocol and pilot study (n=42) is testing ketamine 0.5 mg/kg given under propofol sedation for chronic pain with depression, with pain as the main outcome. In six pilot participants, there were no serious adverse events and propofol seemed to help mask treatment allocation, although many still guessed ketamine immediately after sedation.

Published
April 16, 2026
Journal
Pain Management
Authors
Lii, T. R., Sikka, P., Deverett, B., Altirkawi, O. K., Heifets, B. D.

Quick Facts

Papers Indexed
1
h-Index
37
Open Access
Yes
Publisher
Taylor & Francis
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.